The Latest Cardiac and Vascular News
LONDON, Nov. 16, 2023 /PRNewswire/ — Founder and CEO of CardioThrive, Shelley Savage has dedicated her career to saving lives. Her company’s patented invention, the PocketDefib™, has the potential to dramatically reduce the number of deaths caused by SCA (Sudden cardiac arrest) all over…
SANTA CLARA, Calif.–(BUSINESS WIRE)–HeartBeam Granted Third US Patent for 12-Lead Extended Wear Patch for Detecting Heart Attacks and Complex Cardiac Arrythmias
Powerful and comprehensive health monitoring platform now offers FDA-cleared biomarkers for pulse and respiratory rate BOSTON, Nov. 2, 2023 /PRNewswire/ — Empatica, a digital health and AI company developing medical-grade wearables and digital biomarkers for health monitoring and…
Widely considered the industry’s highest accolade for life sciences research and development, the Prix Galien Awards honor innovative treatments and technologies that improve human health MARSEILLE, France, Nov. 02, 2023 (GLOBE NEWSWIRE) — Volta Medical, a pioneering health technology company developing artificial intelligence (AI) solutions to assist electrophysiologist physicians in […]
ST. LOUIS, Oct. 31, 2023 (GLOBE NEWSWIRE) — Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the first patients in the United States have been treated successfully utilizing Abbott’s EnSite™ X EP System integrated with Stereotaxis’ Robotic Magnetic Navigation System. […]
SHENZHEN, China, Oct. 30, 2023 /PRNewswire/ — Pulsecare Medical, an innovative minimally invasive and non-invasive therapeutic technology company, announced today that its nanosecond pulsed field ablation (nsPFA) system for cardiac electrophysiology, the world’s first third-generation…
ST. LOUIS, Oct. 12, 2023 /PRNewswire/ — SentiAR, Inc. a St. Louis, Missouri based pioneer in using Augmented Reality (AR) visualization technology for medical procedures has received their second FDA 510K clearance CommandEP™ adding a new integration. CommandEP™ integrates existing 3D cardiac mapping systems to create a real time 3D holographic interface that provides physicians with an […]
SAN DIEGO–(BUSINESS WIRE)–Rejuvenate Bio, today announced new preclinical efficacy data for RJB-0402, a gene therapy targeting key disease-mediating pathways. RJB-0402 demonstrated efficacy in a mouse model of arrhythmogenic cardiomyopathy (ACM), an inherited disease caused by mutations in one of several genes encoding desmosomal proteins. A single dose of RJB-0402 was […]
Irvine, CA October 5, 2023 – Biosense Webster, Inc. the global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech,1 announced today new data from a Biosense Webster funded study which sought to compare the risk of heart failure incidence among atrial fibrillation (AFib) patients treated with […]
HAYWARD, Calif.–(BUSINESS WIRE)–Pulse Biosciences, Inc. (Nasdaq: PLSE, “the Company”), a company primarily focused on leveraging its novel and proprietary Nanosecond Pulsed Field Ablation (nsPFA) technology for the treatment of atrial fibrillation, today announced a collaboration with CardioNXT, to support Pulse Biosciences’ planned nsPFA cardiac catheter first-in-human study focused on the […]
